Literature DB >> 32727846

Hepatocyte expression of the micropeptide adropin regulates the liver fasting response and is enhanced by caloric restriction.

Subhashis Banerjee1, Sarbani Ghoshal1, Joseph R Stevens1, Kyle S McCommis2,3,4, Su Gao5, Mauricio Castro-Sepulveda6, Maria L Mizgier7, Clemence Girardet1, K Ganesh Kumar5, Jose E Galgani7, Michael L Niehoff8,9,10, Susan A Farr8,9,10, Jinsong Zhang1, Andrew A Butler11,5,8.   

Abstract

The micropeptide adropin encoded by the clock-controlled energy homeostasis-associated gene is implicated in the regulation of glucose metabolism. However, its links to rhythms of nutrient intake, energy balance, and metabolic control remain poorly defined. Using surveys of Gene Expression Omnibus data sets, we confirm that fasting suppresses liver adropin expression in lean C57BL/6J (B6) mice. However, circadian rhythm data are inconsistent. In lean mice, caloric restriction (CR) induces bouts of compulsive binge feeding separated by prolonged fasting intervals, increasing NAD-dependent deacetylase sirtuin-1 signaling important for glucose and lipid metabolism regulation. CR up-regulates adropin expression and induces rhythms correlating with cellular stress-response pathways. Furthermore, adropin expression correlates positively with phosphoenolpyruvate carboxokinase-1 (Pck1) expression, suggesting a link with gluconeogenesis. Our previous data suggest that adropin suppresses gluconeogenesis in hepatocytes. Liver-specific adropin knockout (LAdrKO) mice exhibit increased glucose excursions following pyruvate injections, indicating increased gluconeogenesis. Gluconeogenesis is also increased in primary cultured hepatocytes derived from LAdrKO mice. Analysis of circulating insulin levels and liver expression of fasting-responsive cAMP-dependent protein kinase A (PKA) signaling pathways also suggests enhanced responses in LAdrKO mice during a glucagon tolerance test (250 µg/kg intraperitoneally). Fasting-associated changes in PKA signaling are attenuated in transgenic mice constitutively expressing adropin and in fasting mice treated acutely with adropin peptide. In summary, hepatic adropin expression is regulated by nutrient- and clock-dependent extrahepatic signals. CR induces pronounced postprandial peaks in hepatic adropin expression. Rhythms of hepatic adropin expression appear to link energy balance and cellular stress to the intracellular signal transduction pathways that drive the liver fasting response.
© 2020 Banerjee et al.

Entities:  

Keywords:  circadian rhythm; diet; glucagon; glucose metabolism; hepatocyte; insulin; peptide hormone; signal transduction; stress response

Year:  2020        PMID: 32727846      PMCID: PMC7535914          DOI: 10.1074/jbc.RA120.014381

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  89 in total

Review 1.  Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover.

Authors:  Roger H Unger; Alan D Cherrington
Journal:  J Clin Invest       Date:  2012-01-03       Impact factor: 14.808

2.  Low circulating adropin concentrations with obesity and aging correlate with risk factors for metabolic disease and increase after gastric bypass surgery in humans.

Authors:  Andrew A Butler; Charmaine S Tam; Kimber L Stanhope; Bruce M Wolfe; Mohamed R Ali; Majella O'Keeffe; Marie-Pierre St-Onge; Eric Ravussin; Peter J Havel
Journal:  J Clin Endocrinol Metab       Date:  2012-08-07       Impact factor: 5.958

3.  Early aging and age-related pathologies in mice deficient in BMAL1, the core componentof the circadian clock.

Authors:  Roman V Kondratov; Anna A Kondratova; Victoria Y Gorbacheva; Olena V Vykhovanets; Marina P Antoch
Journal:  Genes Dev       Date:  2006-07-15       Impact factor: 11.361

Review 4.  Discovery and characterization of smORF-encoded bioactive polypeptides.

Authors:  Alan Saghatelian; Juan Pablo Couso
Journal:  Nat Chem Biol       Date:  2015-12       Impact factor: 15.040

5.  Fish oil supplementation ameliorates fructose-induced hypertriglyceridemia and insulin resistance in adult male rhesus macaques.

Authors:  Andrew A Bremer; Kimber L Stanhope; James L Graham; Bethany P Cummings; Steve B Ampah; Benjamin R Saville; Peter J Havel
Journal:  J Nutr       Date:  2013-10-09       Impact factor: 4.798

6.  Melanocortin-3 receptors are involved in adaptation to restricted feeding.

Authors:  K Begriche; O J Marston; J Rossi; L K Burke; P McDonald; L K Heisler; A A Butler
Journal:  Genes Brain Behav       Date:  2012-02-06       Impact factor: 3.449

7.  Differential Responses of Plasma Adropin Concentrations To Dietary Glucose or Fructose Consumption In Humans.

Authors:  Andrew A Butler; Marie-Pierre St-Onge; Emily A Siebert; Valentina Medici; Kimber L Stanhope; Peter J Havel
Journal:  Sci Rep       Date:  2015-10-05       Impact factor: 4.379

8.  The microRNA-29 Family Dictates the Balance Between Homeostatic and Pathological Glucose Handling in Diabetes and Obesity.

Authors:  James Dooley; Josselyn E Garcia-Perez; Jayasree Sreenivasan; Susan M Schlenner; Roman Vangoitsenhoven; Aikaterini S Papadopoulou; Lei Tian; Susann Schonefeldt; Lutgarde Serneels; Christophe Deroose; Kim A Staats; Bart Van der Schueren; Bart De Strooper; Owen P McGuinness; Chantal Mathieu; Adrian Liston
Journal:  Diabetes       Date:  2016-01       Impact factor: 9.461

9.  Dynamic regulation of PGC-1alpha localization and turnover implicates mitochondrial adaptation in calorie restriction and the stress response.

Authors:  Rozalyn M Anderson; Jamie L Barger; Michael G Edwards; Kristina H Braun; Clare E O'Connor; Tomas A Prolla; Richard Weindruch
Journal:  Aging Cell       Date:  2007-11-21       Impact factor: 9.304

10.  Adropin protects against liver injury in nonalcoholic steatohepatitis via the Nrf2 mediated antioxidant capacity.

Authors:  Xu Chen; Hongliang Xue; Wanjun Fang; Ke Chen; Shen Chen; Wenqi Yang; Tianran Shen; Xuechen Chen; Peiwen Zhang; Wenhua Ling
Journal:  Redox Biol       Date:  2018-12-06       Impact factor: 11.799

View more
  7 in total

1.  Adropin and insulin resistance: Integration of endocrine, circadian, and stress signals regulating glucose metabolism.

Authors:  Andrew A Butler; Peter J Havel
Journal:  Obesity (Silver Spring)       Date:  2021-09-21       Impact factor: 5.002

2.  Adropin transgenesis improves recognition memory in diet-induced obese LDLR-deficient C57BL/6J mice.

Authors:  Sarbani Ghoshal; Subhashis Banerjee; Jinsong Zhang; Michael L Niehoff; Susan A Farr; Andrew A Butler
Journal:  Peptides       Date:  2021-10-22       Impact factor: 3.750

3.  Hepatic Suppression of Mitochondrial Complex II Assembly Drives Systemic Metabolic Benefits.

Authors:  Xueqiang Wang; Weiqiang Lv; Jie Xu; Adi Zheng; Mengqi Zeng; Ke Cao; Xun Wang; Yuting Cui; Hao Li; Meng Yang; Yongping Shao; Fang Zhang; Xuan Zou; Jiangang Long; Zhihui Feng; Jiankang Liu
Journal:  Adv Sci (Weinh)       Date:  2022-01-17       Impact factor: 16.806

4.  Diet-induced obese mice are resistant to improvements in cardiac function resulting from short-term adropin treatment.

Authors:  Dharendra Thapa; Bingxian Xie; Bellina A S Mushala; Manling Zhang; Janet R Manning; Paramesha Bugga; Michael W Stoner; Michael J Jurczak; Iain Scott
Journal:  Curr Res Physiol       Date:  2022-01-25

5.  Hepatic adropin is regulated by estrogen and contributes to adverse metabolic phenotypes in ovariectomized mice.

Authors:  Joshua Stokar; Irina Gurt; Einav Cohen-Kfir; Oran Yakubovsky; Noa Hallak; Hadar Benyamini; Natan Lishinsky; Neta Offir; Joseph Tam; Rivka Dresner-Pollak
Journal:  Mol Metab       Date:  2022-03-29       Impact factor: 8.568

Review 6.  Adropin's Role in Energy Homeostasis and Metabolic Disorders.

Authors:  Ifrah Ismail Ali; Crystal D'Souza; Jaipaul Singh; Ernest Adeghate
Journal:  Int J Mol Sci       Date:  2022-07-28       Impact factor: 6.208

7.  ERα-Dependent Regulation of Adropin Predicts Sex Differences in Liver Homeostasis during High-Fat Diet.

Authors:  Clara Meda; Arianna Dolce; Elisabetta Vegeto; Adriana Maggi; Sara Della Torre
Journal:  Nutrients       Date:  2022-08-10       Impact factor: 6.706

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.